Global DNA Repair Drugs Market Insights and Forecast to 2026

Publisher Name :
Date: 13-Aug-2020
No. of pages: 152
Inquire Before Buying

DNA Repair Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global DNA Repair Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the DNA Repair Drugs market is segmented into

- PARP Inhibitors

- Other

Segment by Application, the DNA Repair Drugs market is segmented into

- Oncological

- Stroke

Regional and Country-level Analysis

The DNA Repair Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the DNA Repair Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and DNA Repair Drugs Market Share Analysis

DNA Repair Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in DNA Repair Drugs business, the date to enter into the DNA Repair Drugs market, DNA Repair Drugs product introduction, recent developments, etc.

The major vendors covered:

- 4SC AG

- ARCAGY/ GINECO GROUP

- Bristol Myers Squibb

- British Columbia Cancer Agency

- Cambridge University Hospitals NHS Foundation Trust

- Genentech

- Georgetown University

- German Breast Group

- GlaxoSmithKline

- Jiangsu Hengrui Medicine

- Johnson & Johnson

- Jonsson Comprehensive Cancer Center

- Karyopharm Therapeutics

- KuDOS Pharmaceuticals

- National Health Service

- National Institutes of Health

- Tesaro

Global DNA Repair Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 DNA Repair Drugs Product Introduction
1.2 Market Segments
1.3 Key DNA Repair Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global DNA Repair Drugs Market Size Growth Rate by Type
1.4.2 PARP Inhibitors
1.4.3 Other
1.5 Market by Application
1.5.1 Global DNA Repair Drugs Market Size Growth Rate by Application
1.5.2 Oncological
1.5.3 Stroke
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global DNA Repair Drugs Market Size, Estimates and Forecasts
2.1.1 Global DNA Repair Drugs Revenue 2015-2026
2.1.2 Global DNA Repair Drugs Sales 2015-2026
2.2 Global DNA Repair Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global DNA Repair Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global DNA Repair Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global DNA Repair Drugs Competitor Landscape by Players
3.1 DNA Repair Drugs Sales by Manufacturers
3.1.1 DNA Repair Drugs Sales by Manufacturers (2015-2020)
3.1.2 DNA Repair Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 DNA Repair Drugs Revenue by Manufacturers
3.2.1 DNA Repair Drugs Revenue by Manufacturers (2015-2020)
3.2.2 DNA Repair Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global DNA Repair Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by DNA Repair Drugs Revenue in 2019
3.2.5 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 DNA Repair Drugs Price by Manufacturers
3.4 DNA Repair Drugs Manufacturing Base Distribution, Product Types
3.4.1 DNA Repair Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers DNA Repair Drugs Product Type
3.4.3 Date of International Manufacturers Enter into DNA Repair Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global DNA Repair Drugs Market Size by Type (2015-2020)
4.1.1 Global DNA Repair Drugs Sales by Type (2015-2020)
4.1.2 Global DNA Repair Drugs Revenue by Type (2015-2020)
4.1.3 DNA Repair Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global DNA Repair Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global DNA Repair Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global DNA Repair Drugs Revenue Forecast by Type (2021-2026)
4.2.3 DNA Repair Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global DNA Repair Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global DNA Repair Drugs Market Size by Application (2015-2020)
5.1.1 Global DNA Repair Drugs Sales by Application (2015-2020)
5.1.2 Global DNA Repair Drugs Revenue by Application (2015-2020)
5.1.3 DNA Repair Drugs Price by Application (2015-2020)
5.2 DNA Repair Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global DNA Repair Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global DNA Repair Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global DNA Repair Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America DNA Repair Drugs by Country
6.1.1 North America DNA Repair Drugs Sales by Country
6.1.2 North America DNA Repair Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America DNA Repair Drugs Market Facts & Figures by Type
6.3 North America DNA Repair Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe DNA Repair Drugs by Country
7.1.1 Europe DNA Repair Drugs Sales by Country
7.1.2 Europe DNA Repair Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe DNA Repair Drugs Market Facts & Figures by Type
7.3 Europe DNA Repair Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific DNA Repair Drugs by Region
8.1.1 Asia Pacific DNA Repair Drugs Sales by Region
8.1.2 Asia Pacific DNA Repair Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific DNA Repair Drugs Market Facts & Figures by Type
8.3 Asia Pacific DNA Repair Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America DNA Repair Drugs by Country
9.1.1 Latin America DNA Repair Drugs Sales by Country
9.1.2 Latin America DNA Repair Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America DNA Repair Drugs Market Facts & Figures by Type
9.3 Central & South America DNA Repair Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa DNA Repair Drugs by Country
10.1.1 Middle East and Africa DNA Repair Drugs Sales by Country
10.1.2 Middle East and Africa DNA Repair Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Type
10.3 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 4SC AG
11.1.1 4SC AG Corporation Information
11.1.2 4SC AG Description and Business Overview
11.1.3 4SC AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 4SC AG DNA Repair Drugs Products Offered
11.1.5 4SC AG Related Developments
11.2 ARCAGY/ GINECO GROUP
11.2.1 ARCAGY/ GINECO GROUP Corporation Information
11.2.2 ARCAGY/ GINECO GROUP Description and Business Overview
11.2.3 ARCAGY/ GINECO GROUP Sales, Revenue and Gross Margin (2015-2020)
11.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Products Offered
11.2.5 ARCAGY/ GINECO GROUP Related Developments
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Corporation Information
11.3.2 Bristol Myers Squibb Description and Business Overview
11.3.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
11.3.5 Bristol Myers Squibb Related Developments
11.4 British Columbia Cancer Agency
11.4.1 British Columbia Cancer Agency Corporation Information
11.4.2 British Columbia Cancer Agency Description and Business Overview
11.4.3 British Columbia Cancer Agency Sales, Revenue and Gross Margin (2015-2020)
11.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
11.4.5 British Columbia Cancer Agency Related Developments
11.5 Cambridge University Hospitals NHS Foundation Trust
11.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
11.5.2 Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
11.5.3 Cambridge University Hospitals NHS Foundation Trust Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
11.5.5 Cambridge University Hospitals NHS Foundation Trust Related Developments
11.6 Genentech
11.6.1 Genentech Corporation Information
11.6.2 Genentech Description and Business Overview
11.6.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Genentech DNA Repair Drugs Products Offered
11.6.5 Genentech Related Developments
11.7 Georgetown University
11.7.1 Georgetown University Corporation Information
11.7.2 Georgetown University Description and Business Overview
11.7.3 Georgetown University Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Georgetown University DNA Repair Drugs Products Offered
11.7.5 Georgetown University Related Developments
11.8 German Breast Group
11.8.1 German Breast Group Corporation Information
11.8.2 German Breast Group Description and Business Overview
11.8.3 German Breast Group Sales, Revenue and Gross Margin (2015-2020)
11.8.4 German Breast Group DNA Repair Drugs Products Offered
11.8.5 German Breast Group Related Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Corporation Information
11.9.2 GlaxoSmithKline Description and Business Overview
11.9.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
11.9.5 GlaxoSmithKline Related Developments
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Corporation Information
11.10.2 Jiangsu Hengrui Medicine Description and Business Overview
11.10.3 Jiangsu Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Products Offered
11.10.5 Jiangsu Hengrui Medicine Related Developments
11.1 4SC AG
11.1.1 4SC AG Corporation Information
11.1.2 4SC AG Description and Business Overview
11.1.3 4SC AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 4SC AG DNA Repair Drugs Products Offered
11.1.5 4SC AG Related Developments
11.12 Jonsson Comprehensive Cancer Center
11.12.1 Jonsson Comprehensive Cancer Center Corporation Information
11.12.2 Jonsson Comprehensive Cancer Center Description and Business Overview
11.12.3 Jonsson Comprehensive Cancer Center Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Jonsson Comprehensive Cancer Center Products Offered
11.12.5 Jonsson Comprehensive Cancer Center Related Developments
11.13 Karyopharm Therapeutics
11.13.1 Karyopharm Therapeutics Corporation Information
11.13.2 Karyopharm Therapeutics Description and Business Overview
11.13.3 Karyopharm Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Karyopharm Therapeutics Products Offered
11.13.5 Karyopharm Therapeutics Related Developments
11.14 KuDOS Pharmaceuticals
11.14.1 KuDOS Pharmaceuticals Corporation Information
11.14.2 KuDOS Pharmaceuticals Description and Business Overview
11.14.3 KuDOS Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.14.4 KuDOS Pharmaceuticals Products Offered
11.14.5 KuDOS Pharmaceuticals Related Developments
11.15 National Health Service
11.15.1 National Health Service Corporation Information
11.15.2 National Health Service Description and Business Overview
11.15.3 National Health Service Sales, Revenue and Gross Margin (2015-2020)
11.15.4 National Health Service Products Offered
11.15.5 National Health Service Related Developments
11.16 National Institutes of Health
11.16.1 National Institutes of Health Corporation Information
11.16.2 National Institutes of Health Description and Business Overview
11.16.3 National Institutes of Health Sales, Revenue and Gross Margin (2015-2020)
11.16.4 National Institutes of Health Products Offered
11.16.5 National Institutes of Health Related Developments
11.17 Tesaro
11.17.1 Tesaro Corporation Information
11.17.2 Tesaro Description and Business Overview
11.17.3 Tesaro Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Tesaro Products Offered
11.17.5 Tesaro Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 DNA Repair Drugs Market Estimates and Projections by Region
12.1.1 Global DNA Repair Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global DNA Repair Drugs Revenue Forecast by Regions 2021-2026
12.2 North America DNA Repair Drugs Market Size Forecast (2021-2026)
12.2.1 North America: DNA Repair Drugs Sales Forecast (2021-2026)
12.2.2 North America: DNA Repair Drugs Revenue Forecast (2021-2026)
12.2.3 North America: DNA Repair Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe DNA Repair Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: DNA Repair Drugs Sales Forecast (2021-2026)
12.3.2 Europe: DNA Repair Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: DNA Repair Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific DNA Repair Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: DNA Repair Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: DNA Repair Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: DNA Repair Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America DNA Repair Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: DNA Repair Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: DNA Repair Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: DNA Repair Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa DNA Repair Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: DNA Repair Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: DNA Repair Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: DNA Repair Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key DNA Repair Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 DNA Repair Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. DNA Repair Drugs Market Segments
Table 2. Ranking of Global Top DNA Repair Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global DNA Repair Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of PARP Inhibitors
Table 5. Major Manufacturers of Other
Table 6. Global DNA Repair Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global DNA Repair Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global DNA Repair Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global DNA Repair Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global DNA Repair Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global DNA Repair Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global DNA Repair Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global DNA Repair Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global DNA Repair Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Repair Drugs as of 2019)
Table 15. DNA Repair Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. DNA Repair Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers DNA Repair Drugs Price (2015-2020) (USD/Unit)
Table 18. DNA Repair Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers DNA Repair Drugs Product Type
Table 20. Date of International Manufacturers Enter into DNA Repair Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global DNA Repair Drugs Sales by Type (2015-2020) (K Units)
Table 23. Global DNA Repair Drugs Sales Share by Type (2015-2020)
Table 24. Global DNA Repair Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global DNA Repair Drugs Revenue Share by Type (2015-2020)
Table 26. DNA Repair Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global DNA Repair Drugs Sales by Application (2015-2020) (K Units)
Table 28. Global DNA Repair Drugs Sales Share by Application (2015-2020)
Table 29. North America DNA Repair Drugs Sales by Country (2015-2020) (K Units)
Table 30. North America DNA Repair Drugs Sales Market Share by Country (2015-2020)
Table 31. North America DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America DNA Repair Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America DNA Repair Drugs Sales by Type (2015-2020) (K Units)
Table 34. North America DNA Repair Drugs Sales Market Share by Type (2015-2020)
Table 35. North America DNA Repair Drugs Sales by Application (2015-2020) (K Units)
Table 36. North America DNA Repair Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe DNA Repair Drugs Sales by Country (2015-2020) (K Units)
Table 38. Europe DNA Repair Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe DNA Repair Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe DNA Repair Drugs Sales by Type (2015-2020) (K Units)
Table 42. Europe DNA Repair Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe DNA Repair Drugs Sales by Application (2015-2020) (K Units)
Table 44. Europe DNA Repair Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific DNA Repair Drugs Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific DNA Repair Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific DNA Repair Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific DNA Repair Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific DNA Repair Drugs Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific DNA Repair Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific DNA Repair Drugs Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific DNA Repair Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America DNA Repair Drugs Sales by Country (2015-2020) (K Units)
Table 54. Latin America DNA Repair Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America DNA Repair Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America DNA Repair Drugs Sales by Type (2015-2020) (K Units)
Table 58. Latin America DNA Repair Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America DNA Repair Drugs Sales by Application (2015-2020) (K Units)
Table 60. Latin America DNA Repair Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa DNA Repair Drugs Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa DNA Repair Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa DNA Repair Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa DNA Repair Drugs Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa DNA Repair Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa DNA Repair Drugs Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa DNA Repair Drugs Sales Market Share by Application (2015-2020)
Table 69. 4SC AG Corporation Information
Table 70. 4SC AG Description and Major Businesses
Table 71. 4SC AG DNA Repair Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. 4SC AG Product
Table 73. 4SC AG Recent Development
Table 74. ARCAGY/ GINECO GROUP Corporation Information
Table 75. ARCAGY/ GINECO GROUP Description and Major Businesses
Table 76. ARCAGY/ GINECO GROUP DNA Repair Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. ARCAGY/ GINECO GROUP Product
Table 78. ARCAGY/ GINECO GROUP Recent Development
Table 79. Bristol Myers Squibb Corporation Information
Table 80. Bristol Myers Squibb Description and Major Businesses
Table 81. Bristol Myers Squibb DNA Repair Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Bristol Myers Squibb Product
Table 83. Bristol Myers Squibb Recent Development
Table 84. British Columbia Cancer Agency Corporation Information
Table 85. British Columbia Cancer Agency Description and Major Businesses
Table 86. British Columbia Cancer Agency DNA Repair Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. British Columbia Cancer Agency Product
Table 88. British Columbia Cancer Agency Recent Development
Table 89. Cambridge University Hospitals NHS Foundation Trust Corporation Information
Table 90. Cambridge University Hospitals NHS Foundation Trust Description and Major Businesses
Table 91. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Cambridge University Hospitals NHS Foundation Trust Product
Table 93. Cambridge University Hospitals NHS Foundation Trust Recent Development
Table 94. Genentech Corporation Information
Table 95. Genentech Description and Major Businesses
Table 96. Genentech DNA Repair Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Genentech Product
Table 98. Genentech Recent Development
Table 99. Georgetown University Corporation Information
Table 100. Georgetown University Description and Major Businesses
Table 101. Georgetown University DNA Repair Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Georgetown University Product
Table 103. Georgetown University Recent Development
Table 104. German Breast Group Corporation Information
Table 105. German Breast Group Description and Major Businesses
Table 106. German Breast Group DNA Repair Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. German Breast Group Product
Table 108. German Breast Group Recent Development
Table 109. GlaxoSmithKline Corporation Information
Table 110. GlaxoSmithKline Description and Major Businesses
Table 111. GlaxoSmithKline DNA Repair Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Product
Table 113. GlaxoSmithKline Recent Development
Table 114. Jiangsu Hengrui Medicine Corporation Information
Table 115. Jiangsu Hengrui Medicine Description and Major Businesses
Table 116. Jiangsu Hengrui Medicine DNA Repair Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Jiangsu Hengrui Medicine Product
Table 118. Jiangsu Hengrui Medicine Recent Development
Table 119. Johnson & Johnson Corporation Information
Table 120. Johnson & Johnson Description and Major Businesses
Table 121. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Johnson & Johnson Product
Table 123. Johnson & Johnson Recent Development
Table 124. Jonsson Comprehensive Cancer Center Corporation Information
Table 125. Jonsson Comprehensive Cancer Center Description and Major Businesses
Table 126. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Jonsson Comprehensive Cancer Center Product
Table 128. Jonsson Comprehensive Cancer Center Recent Development
Table 129. Karyopharm Therapeutics Corporation Information
Table 130. Karyopharm Therapeutics Description and Major Businesses
Table 131. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Karyopharm Therapeutics Product
Table 133. Karyopharm Therapeutics Recent Development
Table 134. KuDOS Pharmaceuticals Corporation Information
Table 135. KuDOS Pharmaceuticals Description and Major Businesses
Table 136. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. KuDOS Pharmaceuticals Product
Table 138. KuDOS Pharmaceuticals Recent Development
Table 139. National Health Service Corporation Information
Table 140. National Health Service Description and Major Businesses
Table 141. National Health Service DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. National Health Service Product
Table 143. National Health Service Recent Development
Table 144. National Institutes of Health Corporation Information
Table 145. National Institutes of Health Description and Major Businesses
Table 146. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. National Institutes of Health Product
Table 148. National Institutes of Health Recent Development
Table 149. Tesaro Corporation Information
Table 150. Tesaro Description and Major Businesses
Table 151. Tesaro DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Tesaro Product
Table 153. Tesaro Recent Development
Table 154. Global DNA Repair Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 155. Global DNA Repair Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 156. Global DNA Repair Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 157. Global DNA Repair Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 158. North America: DNA Repair Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 159. North America: DNA Repair Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Europe: DNA Repair Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 161. Europe: DNA Repair Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Asia Pacific: DNA Repair Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 163. Asia Pacific: DNA Repair Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Latin America: DNA Repair Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 165. Latin America: DNA Repair Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Middle East and Africa: DNA Repair Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 167. Middle East and Africa: DNA Repair Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 169. Key Challenges
Table 170. Market Risks
Table 171. Main Points Interviewed from Key DNA Repair Drugs Players
Table 172. DNA Repair Drugs Customers List
Table 173. DNA Repair Drugs Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. DNA Repair Drugs Product Picture
Figure 2. Global DNA Repair Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. PARP Inhibitors Product Picture
Figure 4. Other Product Picture
Figure 5. Global DNA Repair Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Oncological
Figure 7. Stroke
Figure 8. DNA Repair Drugs Report Years Considered
Figure 9. Global DNA Repair Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global DNA Repair Drugs Sales 2015-2026 (K Units)
Figure 11. Global DNA Repair Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global DNA Repair Drugs Sales Market Share by Region (2015-2020)
Figure 13. Global DNA Repair Drugs Sales Market Share by Region in 2019
Figure 14. Global DNA Repair Drugs Revenue Market Share by Region (2015-2020)
Figure 15. Global DNA Repair Drugs Revenue Market Share by Region in 2019
Figure 16. Global DNA Repair Drugs Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by DNA Repair Drugs Revenue in 2019
Figure 18. DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global DNA Repair Drugs Sales Market Share by Type (2015-2020)
Figure 20. Global DNA Repair Drugs Sales Market Share by Type in 2019
Figure 21. Global DNA Repair Drugs Revenue Market Share by Type (2015-2020)
Figure 22. Global DNA Repair Drugs Revenue Market Share by Type in 2019
Figure 23. Global DNA Repair Drugs Market Share by Price Range (2015-2020)
Figure 24. Global DNA Repair Drugs Sales Market Share by Application (2015-2020)
Figure 25. Global DNA Repair Drugs Sales Market Share by Application in 2019
Figure 26. Global DNA Repair Drugs Revenue Market Share by Application (2015-2020)
Figure 27. Global DNA Repair Drugs Revenue Market Share by Application in 2019
Figure 28. North America DNA Repair Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America DNA Repair Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America DNA Repair Drugs Sales Market Share by Country in 2019
Figure 31. North America DNA Repair Drugs Revenue Market Share by Country in 2019
Figure 32. U.S. DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America DNA Repair Drugs Market Share by Type in 2019
Figure 37. North America DNA Repair Drugs Market Share by Application in 2019
Figure 38. Europe DNA Repair Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe DNA Repair Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe DNA Repair Drugs Sales Market Share by Country in 2019
Figure 41. Europe DNA Repair Drugs Revenue Market Share by Country in 2019
Figure 42. Germany DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. France DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe DNA Repair Drugs Market Share by Type in 2019
Figure 53. Europe DNA Repair Drugs Market Share by Application in 2019
Figure 54. Asia Pacific DNA Repair Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific DNA Repair Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific DNA Repair Drugs Sales Market Share by Region in 2019
Figure 57. Asia Pacific DNA Repair Drugs Revenue Market Share by Region in 2019
Figure 58. China DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. China DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. India DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan D
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs